Ian Landells - Concepedia

Author

Ian Landells

Memorial University of Newfoundland ORCID

Also Known As

I Landells, I. Landells, Ian D R Landells, Ian D. R. Landells, Ian D.R. Landells, Ian DR Landells, Ian Landells

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Memorial University of Newfoundland Nexus Clinical Research (Canada)Health Sciences Centre Centre Hospitalier Universitaire Sainte-Justine Probity Medical Research

About

Ian Landells is an author at Memorial University of Newfoundland specializing in medicine, dermatology, and scleroderma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	470
2	Allergy	3	3	41
3	Allergy Medicine	3	3	41
4	Education	1	1	32
5	Public Health	1	1	12

Ian Landells

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis Amy S. Paller, Elaine C. Siegfried, Richard G. Langley, New England Journal of Medicine	2008	387
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study Ian Landells, Colleen Marano, Ming-Chun Hsu, Journal of the American Academy of Dermatology	2015	220
Topical calcipotriene for morphea/linear scleroderma Bari B. Cunningham, Ian Landells, Craig B. Langman, Journal of the American Academy of Dermatology Morphea/linear SclerodermaSkin PharmacologyWound HealingDermatologyScleroderma	1998	190
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial Kim Papp, Diamant Thaçi, Danielle Marcoux, The Lancet Systemic TreatmentClinical TrialsPediatricsClinical DermatologyPharmacotherapy	2017	147
Web-based continuing medical education (II): Evaluation study of computer-mediated continuing medical education Vernon Curran, Theodore B. Hoekman, Wayne Gulliver, Journal of Continuing Education in the Health Professions	2000	85
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label <scp>CADMUS</scp> Jr study Sandra Philipp, Alan Menter, Arjen Nikkels, British Journal of Dermatology	2020	77
Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study Robert Bissonnette, Richard P. Haydey, L. Rosoph, Journal of the European Academy of Dermatology and Venereology	2017	47
High Prevalence of Psoriatic Arthritis in a Cohort of Patients with Psoriasis Seen in a Dermatology Practice Majed Khraishi, Edgardo Chouela, M. González Béjar, Journal of Cutaneous Medicine and Surgery	2012	44
Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase <scp>III</scp> study Diamant Thaçi, Kim Papp, Danielle Marcoux, British Journal of Dermatology	2019	40
Treatment of Acne Vulgaris and Prevention of Acne Scarring: Canadian Consensus Guidelines W. Stuart Maddin, Ian Landells, Yves Poulin, Journal of Cutaneous Medicine and Surgery MedicineAcne VulgarisSignificant AcneTopical DrugClinical Dermatology	2000	36

Page 1